JB Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,680
Closed -$1.1M 268
2021
Q4
$1.1M Buy
10,680
+1,712
+19% +$164K 0.11% 98
2021
Q3
$785K Buy
+8,968
New +$812K 0.1% 122

Other funds holding SYNH

JB Capital's SYNH Position: Q1 2022 in Review

JB Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 10,680 shares — an estimated $1.1M sold.

JB Capital first reported a position in SYNH in Q3 2021 and held it in 2 quarters. The position peaked at $1.1M in Q4 2021. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

  • JB Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • JB Capital sold 10,680 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $1.1M.
  • JB Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2021 and held it in 2 quarters.
  • JB Capital's Syneos Health, Inc. Class A Common Stock position peaked at $1.1M in Q4 2021.
  • 366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on JB Capital's 13F filing for Q1 2022, filed 19 Apr 2022.